Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Hay fever can send work productivity down the drain

27.04.2007
Employers can blame hay fever for the loss of millions of hours of work productivity this spring.

A new study of nearly 600 people with hay fever symptoms, including sneezing, watery eyes and runny and itchy noses, found that workers missed an hour of work per week during peak hay fever season.

While missing an hour of work a week may seem small, consider that 20 to 50 million Americans suffer from at least some symptoms related to hay fever, or allergic rhinitis, said Sheryl Szeinbach, the study's lead author and a professor of pharmacy practice and administration at Ohio State University.

“That means the potential loss of millions of hours of work productivity, not to mention the associated economic costs,” she said. Some estimates suggest that nearly 4 million days of missed work each year due to allergy symptoms.

Hay fever symptoms can disrupt all areas of life, and study participants cited a lack of sleep and a negative impact on their overall health as the two main reasons for missing work.

Szeinbach suggests that people who suspect they have hay fever get an allergy test, either from a family doctor or an allergist. In previous work, she found that some people with allergy-like symptoms don't actually have allergies. Almost anything can cause allergy-type symptoms - perfumes, sinus infections, exercise, dust, cold air – even if a person doesn't have an allergy.

“Diagnostic testing followed by the right kind of treatment may mean less time out of work,” she said.

The study currently appears on the website for the Primary Care Respiratory Journal.

Szeinbach and her colleagues collected questionnaires from 577 people whose medical and prescription records showed a diagnosis of allergic rhinitis. Participants were asked about the severity and type of allergy symptoms they had, and whether or not they had seen a physician for treatment.

The researchers placed participant responses into one of three groups: 240 patients received care from a family physician; 172 patients saw an allergist for treatment; and 165 chose to self-manage their symptoms (most of the patients in this latter group had been formally tested for allergies by a physician.)

Work time missed due to allergy symptoms ranged from zero to 32 hours a week. Although collectively the participants missed an average of one hour of work per week during the year-long study, most hours were missed during peak hay fever seasons – namely spring and fall. In reality, this may result in missing a couple to several days of work a week during allergy season.

People under the care of a family physician reported a greater severity of symptoms than did patients treated by an allergist as well as those who self-managed their allergy symptoms.

“Family physicians tend to be the gatekeepers to allergists, and as such are more likely to have initial contact with allergy patients,” Szeinbach said. “So it makes sense that family physicians would see patients with a broad spectrum of allergy symptoms.

“Both kinds of physicians have access to thorough diagnostic tests, and can also prescribe heavy-duty allergy drugs, such as steroids that help block the body's natural reaction to allergens,” she continued. Participants who self-managed their allergies relied on over-the-counter products to control their milder symptoms.

A lack of sleep and a decrease in quality of life had the greatest impact on a person's ability to work, regardless of the treatment group they were in. Participants also cited watery eyes and sneezing as having a moderately negative effect on their productivity at work.

While hay fever may remain a fact of life for millions of people, Szeinbach points out the importance of a proper diagnosis. The majority of study participants (405) had a traditional skin-prick test, in which a drop of allergen is placed on a patient's arm or back. The physician then pricks the skin through the drop, which lets the allergen enter the body. The doctor and patient then wait for a reaction, which could indicate an allergy.

About one out of five participants in the study underwent a blood test that evaluates the reaction of immunoglobulin E (IgE) to specific allergens, such as pollen from grass and trees. IgE is an antibody that triggers allergic reactions. In a previous study, Szeinbach found that the ImmunoCAP IgE blood test was more accurate in diagnosing allergies when compared to other specific IgE blood tests.

While IgE testing is traditionally the realm of allergists, more and more family physicians are starting to use it, she said. But patients who think they may have allergies need to ask if their family doctor has access to this test.

“Managed care protocols still need to be changed to allow for the increased use of this test,” Szeinbach said. “The change in practice could result in far fewer missed workdays.”

She conducted the study with Ohio State colleagues Enrique Seoane-Vazquez, assistant professor of pharmacy practice and administration, and Andrew Beyer, a pharmacy doctoral student, and also with P. Brock Williams with the University of Missouri Medical School in Kansas City .

Funding for this study was provided by an unrestricted educational grant from Phadia US Inc., manufacturer of the ImmunoCAP IgE test. Szeinbach and her colleagues have no ties to the company beyond the scope of this work.

Sheryl Szeinbach | EurekAlert!
Further information:
http://www.ohio-state.edu

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>